SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-15-002950
Filing Date
2015-11-13
Accepted
2015-11-13 15:53:21
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q entiabiosciences10q093015.htm 10-Q 890407
2 EX-31.1 ex31-1.htm EX-31.1 14259
3 EX-31.2 ex31-2.htm EX-31.2 13921
4 EX-32.1 ex32-1.htm EX-32.1 7489
5 EX-32.2 ex32-2.htm EX-32.2 7150
12 GRAPHIC logo.jpg GRAPHIC 17300
  Complete submission text file 0001185185-15-002950.txt   5550759

Data Files

Seq Description Document Type Size
6 EX-101.INS ergo-20150930.xml EX-101.INS 1283957
7 EX-101.SCH ergo-20150930.xsd EX-101.SCH 56094
8 EX-101.CAL ergo-20150930_cal.xml EX-101.CAL 31192
9 EX-101.DEF ergo-20150930_def.xml EX-101.DEF 297588
10 EX-101.LAB ergo-20150930_lab.xml EX-101.LAB 392605
11 EX-101.PRE ergo-20150930_pre.xml EX-101.PRE 302671
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 844-559-9910
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52864 | Film No.: 151229049
SIC: 2833 Medicinal Chemicals & Botanical Products